These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 38903163)
1. Dyskinetic crisis in Domínguez Carral J; Reinhard C; Ebrahimi-Fakhari D; Dorison N; Galosi S; Garone G; Malenica M; Ravelli C; Serdaroglu E; van de Pol LA; Koy A; Leuzzi V; Roubertie A; Lin JP; Doummar D; Cif L; Ortigoza-Escobar JD Front Neurol; 2024; 15():1403815. PubMed ID: 38903163 [TBL] [Abstract][Full Text] [Related]
2. Deep brain stimulation is effective in pediatric patients with GNAO1 associated severe hyperkinesia. Koy A; Cirak S; Gonzalez V; Becker K; Roujeau T; Milesi C; Baleine J; Cambonie G; Boularan A; Greco F; Perrigault PF; Cances C; Dorison N; Doummar D; Roubertie A; Beroud C; Körber F; Stüve B; Waltz S; Mignot C; Nava C; Maarouf M; Coubes P; Cif L J Neurol Sci; 2018 Aug; 391():31-39. PubMed ID: 30103967 [TBL] [Abstract][Full Text] [Related]
3. Deep brain stimulation in a young child with Fung EL; Mo CY; Fung ST; Chan AY; Lau KY; Chan EK; Chan DY; Zhu XL; Chan DT; Poon WS Surg Neurol Int; 2022; 13():285. PubMed ID: 35855141 [TBL] [Abstract][Full Text] [Related]
4. Clinical and Molecular Profiling in GNAO1 Permits Phenotype-Genotype Correlation. Lasa-Aranzasti A; Larasati YA; da Silva Cardoso J; Solis GP; Koval A; Cazurro-Gutiérrez A; Ortigoza-Escobar JD; Miranda MC; De la Casa-Fages B; Moreno-Galdó A; Tizzano EF; Gómez-Andrés D; Verdura E; Katanaev VL; Pérez-Dueñas B; Mov Disord; 2024 Jun; ():. PubMed ID: 38881224 [TBL] [Abstract][Full Text] [Related]
5. Association of early-onset epileptic encephalopathy with involuntary movements - Case series and literature review. Arisaka A; Nakashima M; Kumada S; Inoue K; Nishida H; Mashimo H; Kashii H; Kato M; Maruyama K; Okumura A; Saitsu H; Matsumoto N; Fukuda M Epilepsy Behav Rep; 2021; 15():100417. PubMed ID: 33490948 [TBL] [Abstract][Full Text] [Related]
6. Both subthalamic and pallidal deep brain stimulation are effective for Liu Y; Zhang Q; Wang J; Liu J; Yang W; Yan X; Ouyang Y; Yang H Ther Adv Neurol Disord; 2022; 15():17562864221093507. PubMed ID: 35509770 [TBL] [Abstract][Full Text] [Related]
7. Results of the First GNAO1-Related Neurodevelopmental Disorders Caregiver Survey. Axeen E; Bell E; Robichaux Viehoever A; Schreiber JM; Sidiropoulos C; Goodkin HP Pediatr Neurol; 2021 Aug; 121():28-32. PubMed ID: 34139551 [TBL] [Abstract][Full Text] [Related]
8. Spectrum of movement disorders in GNAO1 encephalopathy: in-depth phenotyping and case-by-case analysis. Kim SY; Shim Y; Ko YJ; Park S; Jang SS; Lim BC; Kim KJ; Chae JH Orphanet J Rare Dis; 2020 Dec; 15(1):343. PubMed ID: 33298085 [TBL] [Abstract][Full Text] [Related]
9. GNAO1-related movement disorder: An update on phenomenology, clinical course, and response to treatments. Novelli M; Galosi S; Zorzi G; Martinelli S; Capuano A; Nardecchia F; Granata T; Pollini L; Di Rocco M; Marras CE; Nardocci N; Leuzzi V Parkinsonism Relat Disord; 2023 Jun; 111():105405. PubMed ID: 37142469 [TBL] [Abstract][Full Text] [Related]
11. An intronic GNAO1 variant leading to in-frame insertion cause movement disorder controlled by deep brain stimulation. Miyamoto S; Nakashima M; Fukumura S; Kumada S; Saitsu H Neurogenetics; 2022 Apr; 23(2):129-135. PubMed ID: 35147852 [TBL] [Abstract][Full Text] [Related]
12. Gonadal mosaicism in GNAO1 causing neurodevelopmental disorder with involuntary movements; two additional variants. Al Masseri Z; AlSayed M Mol Genet Metab Rep; 2022 Jun; 31():100864. PubMed ID: 35782616 [TBL] [Abstract][Full Text] [Related]
13. A patient with a GNAO1 mutation with decreased spontaneous movements, hypotonia, and dystonic features. Okumura A; Maruyama K; Shibata M; Kurahashi H; Ishii A; Numoto S; Hirose S; Kawai T; Iso M; Kataoka S; Okuno Y; Muramatsu H; Kojima S Brain Dev; 2018 Nov; 40(10):926-930. PubMed ID: 29935962 [TBL] [Abstract][Full Text] [Related]
14. Genotype-phenotype correlation and treatment effects in young patients with Thiel M; Bamborschke D; Janzarik WG; Assmann B; Zittel S; Patzer S; Auhuber A; Opp J; Matzker E; Bevot A; Seeger J; van Baalen A; Stüve B; Brockmann K; Cirak S; Koy A J Neurol Neurosurg Psychiatry; 2023 Oct; 94(10):806-815. PubMed ID: 37225406 [TBL] [Abstract][Full Text] [Related]
15. Spectrum of neurodevelopmental disease associated with the GNAO1 guanosine triphosphate-binding region. Kelly M; Park M; Mihalek I; Rochtus A; Gramm M; Pérez-Palma E; Axeen ET; Hung CY; Olson H; Swanson L; Anselm I; Briere LC; High FA; Sweetser DA; ; Kayani S; Snyder M; Calvert S; Scheffer IE; Yang E; Waugh JL; Lal D; Bodamer O; Poduri A Epilepsia; 2019 Mar; 60(3):406-418. PubMed ID: 30682224 [TBL] [Abstract][Full Text] [Related]
16. GNAO1 Mutation-Induced Pediatric Dystonic Storm Rescue With Pallidal Deep Brain Stimulation. Honey CM; Malhotra AK; Tarailo-Graovac M; van Karnebeek CDM; Horvath G; Sulistyanto A J Child Neurol; 2018 May; 33(6):413-416. PubMed ID: 29661126 [TBL] [Abstract][Full Text] [Related]
17. The Genetic Landscape of Complex Childhood-Onset Hyperkinetic Movement Disorders. Pérez-Dueñas B; Gorman K; Marcé-Grau A; Ortigoza-Escobar JD; Macaya A; Danti FR; Barwick K; Papandreou A; Ng J; Meyer E; Mohammad SS; Smith M; Muntoni F; Munot P; Uusimaa J; Vieira P; Sheridan E; Guerrini R; Cobben J; Yilmaz S; De Grandis E; Dale RC; Pons R; Peall KJ; Leuzzi V; Kurian MA Mov Disord; 2022 Nov; 37(11):2197-2209. PubMed ID: 36054588 [TBL] [Abstract][Full Text] [Related]
18. GNAO1 mutation-related severe involuntary movements treated with gabapentin. Akasaka M; Kamei A; Tanifuji S; Asami M; Ito J; Mizuma K; Oyama K; Tokutomi T; Yamamoto K; Fukushima A; Takenouchi T; Uehara T; Suzuki H; Kosaki K Brain Dev; 2021 Apr; 43(4):576-579. PubMed ID: 33358199 [TBL] [Abstract][Full Text] [Related]
19. A mechanistic review on GNAO1-associated movement disorder. Feng H; Khalil S; Neubig RR; Sidiropoulos C Neurobiol Dis; 2018 Aug; 116():131-141. PubMed ID: 29758257 [TBL] [Abstract][Full Text] [Related]